These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9017793)

  • 1. Photohemolytic potency of oral antidiabetic drugs in vitro: effects of antioxidants and a nitrogen atmosphere.
    Selvaag E
    Photodermatol Photoimmunol Photomed; 1996 Aug; 12(4):166-70. PubMed ID: 9017793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of phototoxic properties of oral antidiabetics and diuretics. Photohemolysis model as a screening method for recognizing potential photosensitizing drugs.
    Selvaag E
    Arzneimittelforschung; 1997 Sep; 47(9):1031-4. PubMed ID: 9342417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of thiazide photohemolysis in vitro by antioxidants and a nitrogen atmosphere.
    Selvaag E
    Photodermatol Photoimmunol Photomed; 1996 Oct; 12(5):211-5. PubMed ID: 9112280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting effects of antioxidants on drug-induced phototoxicity in cell cultures. Investigations with sulphonamide-derived oral antidiabetics and diuretics.
    Selvaag E; Anholt H; Moan J; Thune P
    J Photochem Photobiol B; 1997 Mar; 38(1):88-93. PubMed ID: 9134756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phototoxicity to sulphonamide-derived oral antidiabetics and diuretics: investigations in hairless mice.
    Selvaag E; Thune P
    Photodermatol Photoimmunol Photomed; 1997; 13(1-2):4-8. PubMed ID: 9361121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phototoxic lysis of erythrocytes from humans is reduced after oral intake of ascorbic acid and d-alpha-tocopherol.
    Eberlein-König B; Placzek M; Przybilla B
    Photodermatol Photoimmunol Photomed; 1997; 13(5-6):173-7. PubMed ID: 9542752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HYPOGLYCEMIA INDUCED BY ANTIDIABETIC SULFONYLUREAS.
    Confederat L; Constantin S; Lupaşcu F; Pânzariu A; Hăncianu M; Profire L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):579-84. PubMed ID: 26204670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.
    O'Brien RC; Luo M
    Metabolism; 1997 Dec; 46(12 Suppl 1):22-5. PubMed ID: 9439554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the phototoxic effects of oral antidiabetics and diuretics.
    Selvaag E
    Arzneimittelforschung; 1997 Jan; 47(1):97-100. PubMed ID: 9037453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phototoxicity due to sulphonamide derived oral antidiabetics and diuretics: investigations in a cell culture model.
    Selvaag E; Anholt H; Moan J; Thune P
    Photodermatol Photoimmunol Photomed; 1996 Feb; 12(1):1-6. PubMed ID: 8884891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaugmentation effects demonstrated in vitro.
    Selvaag E
    Photodermatol Photoimmunol Photomed; 1996 Dec; 12(6):227-32. PubMed ID: 9181606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodegradation and in vitro phototoxicity of the antidiabetic drug chlorpropamide.
    Vargas F; Matskevitch V; Sarabia Z
    Arzneimittelforschung; 1995 Oct; 45(10):1079-81. PubMed ID: 8595063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.
    Douros A; Yin H; Yu OHY; Filion KB; Azoulay L; Suissa S
    Diabetes Care; 2017 Nov; 40(11):1506-1513. PubMed ID: 28864502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of hypoglycemia in users of sulfonylureas.
    van Staa T; Abenhaim L; Monette J
    J Clin Epidemiol; 1997 Jun; 50(6):735-41. PubMed ID: 9250272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypoglycemia caused by oral antidiabetic agents].
    de Baere H; Decraene P; de Leeuw I; Lemmens P; Verhaegen H
    Ned Tijdschr Geneeskd; 1973 Jul; 117(27):1021-4. PubMed ID: 4206176
    [No Abstract]   [Full Text] [Related]  

  • 17. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE].
    KLINGER R; DALLECOSTE P
    Minerva Med; 1964 Jul; 55():2237-40. PubMed ID: 14179829
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypoglycemic accidents during treatment with antidiabetic sulfamides. Apropos of 5 cases of hypoglycemic coma in aged subjects].
    Brogard JM; Kuntzmann F; Touitou D; Dorner M
    Sem Hop; 1973 Sep; 49(37):2461-6. PubMed ID: 4359498
    [No Abstract]   [Full Text] [Related]  

  • 19. An open comparative study of the efficacy and tolerance of a new antidiabetic agent: glipizide.
    De Leeuw I; De Baere H; Decraene P; Lemmens P; Verhaegen H
    Diabetologia; 1973 Sep; ():364-6. PubMed ID: 4204093
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
    Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW
    Brain Res; 2014 May; 1564():33-40. PubMed ID: 24713348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.